Tempest Therapeutics Inc. (TPST)
NASDAQ · Healthcare
Tempest Therapeutics Inc. Net Income 2013–2017
Tempest Therapeutics Inc. annual/quarterly net income history and growth rate from 2013 to 2018. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Tempest Therapeutics Inc. net income for the quarter ending September 30, 2018 was -7.5 M, a 19.55% decrease year-over-year.
- Tempest Therapeutics Inc. net income for the twelve months ending September 30, 2018 was -26.0 M, a 63.34% decrease year-over-year.
- Tempest Therapeutics Inc. annual net income for 2017 was -84.6 M, a 2.82% increase from 2016.
- Tempest Therapeutics Inc. annual net income for 2016 was -82.3 M, a 12.35% increase from 2015.
- Tempest Therapeutics Inc. annual net income for 2015 was -73.2 M, a 47.86% increase from 2014.
- Tempest Therapeutics Inc. annual net income for 2014 was -49.5 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Tempest Therapeutics Inc. Net Income — FAQ
Tempest Therapeutics Inc. (TPST) net income over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is Tempest Therapeutics Inc.'s net income?
Tempest Therapeutics Inc. (TPST) reported net income of -$85M for fiscal 2017.
Where can I see TPST's net income history?
The chart and table above show Tempest Therapeutics Inc.'s net income by year and by quarter, including the growth rate.